⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 1, 2025

Supplemental Table 2 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

Howard L. Li Soren Charmsaz Mari Nakazawa Stephanie Alden Madelena Brancati James M. Leatherman Ervin Griffin Hua‐Ling Tsai Nicole Groß Christopher J. Thoburn Alexei Hernandez Erin M. Coyne Sarah M. Shin Royce P. Lee Evan J. Lipson Burles A. Johnson Aliyah Pabani Yasser Ged Marina Baretti Julie R. Brahmer Jean Hoffman‐Censits Tanguy Y. Seiwert Daniel J. Zabransky Jennifer N. Durham Elizabeth M. Jaffee G. Scott Chandler Brittany L. Adler Won Jin Ho Chester Kao Mark Yarchoan

View Full Paper

Ask AI

Bookmark

Share

Key Points

findings reveal a link between immune activation and fatigue in cancer patients undergoing therapy, indicating new areas for research.
results suggest specific antigens associated with immune responses that may contribute to fatigue, highlighting potential therapeutic targets.
assessed through CyTOF analysis, this research sheds light on the mechanisms behind fatigue during immune checkpoint inhibitor therapy.
implications are significant as they point to the need for strategies addressing fatigue in cancer treatments using immune therapies.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Analysis identifies antigens related to immune activation and fatigue in cancer patients, suggesting potential biomarkers.

Abstract

Supplemental Table 2 shows antigens for CyTOF identification.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a217d0 https://doi.org/10.1158/2767-9764.30256035

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table 6 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy2025
2Supplemental Table 5 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy2025
3Supplemental Table 1 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy2025 · 1 citations
4Supplemental Table 3 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy2025
5Supplemental Table 4 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy2025